Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators

This Letter describes a novel series of GIRK activators identified through an HTS campaign. The HTS lead was a potent and efficacious dual GIRK1/2 and GIRK1/4 activator. Further chemical optimization through both iterative parallel synthesis and fragment library efforts identified dual GIRK1/2 and G...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 23; no. 18; pp. 5195 - 5198
Main Authors Ramos-Hunter, Susan J., Engers, Darren W., Kaufmann, Kristian, Du, Yu, Lindsley, Craig W., Weaver, C. David, Sulikowski, Gary A.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.09.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This Letter describes a novel series of GIRK activators identified through an HTS campaign. The HTS lead was a potent and efficacious dual GIRK1/2 and GIRK1/4 activator. Further chemical optimization through both iterative parallel synthesis and fragment library efforts identified dual GIRK1/2 and GIRK1/4 activators as well as the first examples of selective GIRK1/4 activators. Importantly, these compounds were inactive on GIRK2 and other non-GIRK1 containing GIRK channels, and SAR proved shallow.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2013.07.002
NIH RePORTER
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2013.07.002